Ethanol Effects on Antigen Presentation in Liver Cells

乙醇对肝细胞中抗原呈递的影响

基本信息

项目摘要

DESCRIPTION (provided by applicant): The major objective of the proposed R21 investigation is to examine the influence of ethanol and ethanol metabolism on major histocompatibility complex (MHC) class l-restricted presentation of antigenic peptides in ethanol-metabolizing liver cell lines. After activation with interferon gamma (IFNy), these peptides are cleaved by major antigen-trimming enzymes, the proteasome and leucine amino peptidase. Our previous investigations have indicated that ethanol suppresses proteasome activity in ethanol-metabolizing HepG2 cells, and that these ethanol-treated cells do not properly transduce the IFNy signal. We hypothesize that in liver cells, ethanol metabolism blocks IFNy-mediated signal transduction. This impairs IFNy-regulated induction of the immunoproteasome and of leucine amino peptidase, compromising their ability to generate peptides for antigen presentation and may alter immune response. We therefore propose the following Specific Aims: SPECIFIC AIM 1: To investigate whether ethanol or its metabolism affects the IFNy-induced cleavage of peptides for MHC class l-restricted antigen presentation in mouse recombinant HepB6 cells and in human recombinant HepG2 cells that express alcohol dehydrogenase and cytochrome P4502E1. SPECIFIC AIM 2: To determine whether ethanol exposure affects IFNy-mediated signal transduction by examining ethanol-elicited alterations in specific components of the JAK-STAT1 signal transduction pathway in mouse recombinant HepB6 cells and in human recombinant HepG2 cells. SPECIFIC AIM 3: To determine whether ethanol or its metabolism affects MHC class l-restricted antigen presentation by liver cells, using a model of the intracellular cleavage of ovalbumin (OVA) and the presentation of OVA peptide SIINFEKL-H-2Kb complex on the surface of mouse recombinant HepB6 cells. The results derived from this study will clarify the link between the effects of ethanol on antigen presentation by liver cells, altered immune response and the possible mechanisms of alcohol-related progression of viral hepatitis.
描述(由申请方提供):拟定R21研究的主要目的是检查乙醇和乙醇代谢对乙醇代谢肝细胞系中抗原肽的主要组织相容性复合体(MHC)I类限制性呈递的影响。在用干扰素γ(IFN γ)活化后,这些肽被主要的抗原修剪酶(蛋白酶体和亮氨酸氨基肽酶)切割。我们先前的研究已经表明,乙醇抑制乙醇代谢HepG2细胞中的蛋白酶体活性,并且这些乙醇处理的细胞不能适当地抑制IFN γ信号。我们假设在肝细胞中,乙醇代谢阻断IFN γ介导的信号转导。这损害了IFN γ调节的免疫蛋白酶体和亮氨酸氨基肽酶的诱导,损害了它们产生用于抗原呈递的肽的能力,并可能改变免疫应答。因此,我们提出了以下具体目的:具体目的1:研究乙醇或其代谢是否影响IFN γ诱导的肽切割,用于表达乙醇脱氢酶和细胞色素P4502E1的小鼠重组HepB6细胞和人重组HepG2细胞中的MHC I类限制性抗原呈递。具体目标2:通过检测小鼠重组HepB6细胞和人重组HepG2细胞中乙醇引起的JAK-STAT1信号转导途径特定组分的改变,确定乙醇暴露是否影响IFN γ介导的信号转导。具体目标3:为了确定乙醇或其代谢是否影响肝细胞的MHC I类限制性抗原呈递,使用卵清蛋白(OVA)的细胞内切割和小鼠重组HepB6细胞表面的OVA肽SIINFEKL-H-2Kb复合物的呈递模型。这项研究的结果将阐明乙醇对肝细胞抗原呈递的影响,改变免疫反应和酒精相关的病毒性肝炎进展的可能机制之间的联系。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Implication of altered proteasome function in alcoholic liver injury.
蛋白酶体功能改变对酒精性肝损伤的影响。
  • DOI:
    10.3748/wjg.v13.i37.4931
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    4.3
  • 作者:
    Osna,NataliaA;DonohueJr,Terrence-M
  • 通讯作者:
    DonohueJr,Terrence-M
Ethanol metabolism alters major histocompatibility complex class I-restricted antigen presentation in liver cells.
  • DOI:
    10.1002/hep.22787
  • 发表时间:
    2009-04
  • 期刊:
  • 影响因子:
    13.5
  • 作者:
    Osna, Natalia A.;White, Ronda L.;Thiele, Geoffrey M.;Donohue, Terrence M., Jr.
  • 通讯作者:
    Donohue, Terrence M., Jr.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NATALIA ALEKSANDR OSNA其他文献

NATALIA ALEKSANDR OSNA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NATALIA ALEKSANDR OSNA', 18)}}的其他基金

Alcohol Promotes Hepatitis B Progression by Impairment of Innate Immunity in Liver Cells
酒精通过损害肝细胞的先天免疫促进乙型肝炎的进展
  • 批准号:
    10526257
  • 财政年份:
    2023
  • 资助金额:
    $ 17.69万
  • 项目类别:
Extracellular vesicles as the vehicles for promoting liver injury induced by HIV and alcohol
细胞外囊泡作为促进 HIV 和酒精引起的肝损伤的载体
  • 批准号:
    10355439
  • 财政年份:
    2019
  • 资助金额:
    $ 17.69万
  • 项目类别:
Extracellular vesicles as the vehicles for promoting liver injury induced by HIV and alcohol
细胞外囊泡作为促进 HIV 和酒精引起的肝损伤的载体
  • 批准号:
    10091967
  • 财政年份:
    2019
  • 资助金额:
    $ 17.69万
  • 项目类别:
Extracellular vesicles as the vehicles for promoting liver injury induced by HIV and alcohol
细胞外囊泡作为促进 HIV 和酒精引起的肝损伤的载体
  • 批准号:
    10560567
  • 财政年份:
    2019
  • 资助金额:
    $ 17.69万
  • 项目类别:
Ethanol-Induced Hypomethylation Accelerates Hepatitis C Progression
乙醇诱导的低甲基化加速丙型肝炎进展
  • 批准号:
    8803315
  • 财政年份:
    2013
  • 资助金额:
    $ 17.69万
  • 项目类别:
Ethanol-Induced Hypomethylation Accelerates Hepatitis C Progression
乙醇诱导的低甲基化加速丙型肝炎进展
  • 批准号:
    8689749
  • 财政年份:
    2013
  • 资助金额:
    $ 17.69万
  • 项目类别:
Ethanol-Induced Hypomethylation Accelerates Hepatitis C Progression
乙醇诱导的低甲基化加速丙型肝炎进展
  • 批准号:
    8540051
  • 财政年份:
    2013
  • 资助金额:
    $ 17.69万
  • 项目类别:
Effects of Ethanol on Proteasome-HCV Core Protein Interactions
乙醇对蛋白酶体-HCV 核心蛋白相互作用的影响
  • 批准号:
    7783877
  • 财政年份:
    2009
  • 资助金额:
    $ 17.69万
  • 项目类别:
Ethanol Effects on Antigen Presentation in Liver Cells
乙醇对肝细胞中抗原呈递的影响
  • 批准号:
    6966448
  • 财政年份:
    2005
  • 资助金额:
    $ 17.69万
  • 项目类别:

相似海外基金

Elucidating a molecular understanding of ILC2 MHC class I antigen cross priming
阐明 ILC2 MHC I 类抗原交叉引发的分子理解
  • 批准号:
    486527
  • 财政年份:
    2022
  • 资助金额:
    $ 17.69万
  • 项目类别:
    Studentship Programs
Restoring MHC class I antigen presentation to enhance anti-tumour immunity
恢复MHC I类抗原呈递,增强抗肿瘤免疫力
  • 批准号:
    nhmrc : GNT1164054
  • 财政年份:
    2020
  • 资助金额:
    $ 17.69万
  • 项目类别:
    Project Grants
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
  • 批准号:
    8996707
  • 财政年份:
    2014
  • 资助金额:
    $ 17.69万
  • 项目类别:
Ubiquitin conjugation and direct MHC class I antigen presentation
泛素结合和直接 MHC I 类抗原呈递
  • 批准号:
    8880646
  • 财政年份:
    2014
  • 资助金额:
    $ 17.69万
  • 项目类别:
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
  • 批准号:
    9206412
  • 财政年份:
    2014
  • 资助金额:
    $ 17.69万
  • 项目类别:
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
  • 批准号:
    8723605
  • 财政年份:
    2014
  • 资助金额:
    $ 17.69万
  • 项目类别:
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
  • 批准号:
    8072956
  • 财政年份:
    2010
  • 资助金额:
    $ 17.69万
  • 项目类别:
The function of the Ubiquitin-Proteasome-System (UPS) in MHC class I antigen processing in target cells and maturing human dendritic cells (hDCs).
泛素蛋白酶体系统 (UPS) 在靶细胞和成熟人树突细胞 (hDC) 中 MHC I 类抗原加工中的功能。
  • 批准号:
    105348415
  • 财政年份:
    2009
  • 资助金额:
    $ 17.69万
  • 项目类别:
    Research Grants
In vivo analysis of the imnportance of proteasome immunosubunits and of PA28 for MHC class I antigen processing, CTL response induction and tumor-virus elimination (A 7)
体内分析蛋白酶体免疫亚基和 PA28 对于 MHC I 类抗原加工、CTL 反应诱导和肿瘤病毒消除的重要性 (A 7)
  • 批准号:
    5354871
  • 财政年份:
    2002
  • 资助金额:
    $ 17.69万
  • 项目类别:
    Collaborative Research Centres
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
  • 批准号:
    7991835
  • 财政年份:
    2001
  • 资助金额:
    $ 17.69万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了